The Department of Health and Human Services (HHS) recently canceled more than $750 million in contracts for Moderna to develop and test mRNA vaccines to protect against pandemic flu. Moderna’s RSV ...

Novavax NVAX announced encouraging results from an initial cohort of a late-stage study evaluating its experimental ...

Novavax's experimental COVID-19-influenza combination and standalone influenza vaccines generated a strong immune response in ...